Plaque Modification Devices - Global Market Outlook (2019-2027)

   |      |      |  

Plaque Modification Devices - Global Market Outlook (2019-2027)

"The Global Plaque Modification Devices Market is accounted for $1.21 billion in 2019 and is expected to reach $2.57 billion by 2027 growing at a CAGR of 9.9% during the forecast period. Favourable reimbursement policies and an increase in the trend of adoption of minimally invasive surgeries are the major factors propelling market growth. However, the lack of accessibility and affordability in developing countries is hampering the growth of the market.

Plaque modification devices clear out the blockage in the arteries, helping them regain their normal function resulting in improved blood circulation and heart function. Plaque in the arteries is a deposition of fat on the walls of arteries, which narrow the artery and reduce blood flow.

Based on the product, the atherectomy devices segment is going to have a lucrative growth during the forecast period due to the increasing incidence of atherosclerosis as a result of the rising global prevalence of obesity. Furthermore, the easy availability of these devices drives the growth of the market segment of these products in the plaque modification devices market.

By geography, Asia Pacific is going to have a lucrative growth during the forecast period due to the increase in the prevalence of plaque deposition and cardiovascular and hypertension conditions in the region. Rise in incidences of heart diseases in geriatric population, faster adoption of minimally invasive surgeries, and an increase in the patient population is also likely to drive the demand for plaque modification devices. Presence of key players in the region offering innovative thrombectomy and embolic protection devices for accurate removal of thrombus or clots is expected to propel the plaque modification devices market in the Asia Pacific.

Some of the key players profiled in the Plaque Modification Devices Market include B. Braun Melsungen, BD (Becton Dickinson and Company), Biotronik, Boston Scientific Corporation, Cardinal Health, Cardiovascular Systems Inc, Codman Neuro, Medtronic, Microvention, Inc, Penumbra, Inc, and Stryker.

Products Covered:
• Atherectomy Devices
• Chronic Total Occlusion (CTO) Devices
• Embolic Protection Devices (EPD)
• Thrombectomy Devices

Applications Covered:
• Coronary Artery Disease
• Neurovascular Disease
• Peripheral Artery Disease

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Speciality Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Plaque Modification Devices Market, By Product
5.1 Introduction
5.2 Atherectomy Devices
5.3 Chronic Total Occlusion (CTO) Devices
5.4 Embolic Protection Devices (EPD)
5.5 Thrombectomy Devices

6 Global Plaque Modification Devices Market, By Application
6.1 Introduction
6.2 Coronary Artery Disease
6.3 Neurovascular Disease
6.4 Peripheral Artery Disease

7 Global Plaque Modification Devices Market, By End User
7.1 Introduction
7.2 Ambulatory Surgical Centers
7.3 Hospitals
7.4 Speciality Clinics

8 Global Plaque Modification Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 B. Braun Melsungen
10.2 BD (Becton Dickinson and Company)
10.3 Biotronik
10.4 Boston Scientific Corporation
10.5 Cardinal Health
10.6 Cardiovascular Systems Inc
10.7 Codman Neuro
10.8 Medtronic
10.9 Microvention, Inc
10.10 Penumbra, Inc
10.11 Stryker

List of Tables
Table 1 Global Plaque Modification Devices Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Plaque Modification Devices Market Outlook, By Product (2018-2027) ($MN)
Table 3 Global Plaque Modification Devices Market Outlook, By Atherectomy Devices (2018-2027) ($MN)
Table 4 Global Plaque Modification Devices Market Outlook, By Chronic Total Occlusion (CTO) Devices (2018-2027) ($MN)
Table 5 Global Plaque Modification Devices Market Outlook, By Embolic Protection Devices (EPD) (2018-2027) ($MN)
Table 6 Global Plaque Modification Devices Market Outlook, By Thrombectomy Devices (2018-2027) ($MN)
Table 7 Global Plaque Modification Devices Market Outlook, By Application (2018-2027) ($MN)
Table 8 Global Plaque Modification Devices Market Outlook, By Coronary Artery Disease (2018-2027) ($MN)
Table 9 Global Plaque Modification Devices Market Outlook, By Neurovascular Disease (2018-2027) ($MN)
Table 10 Global Plaque Modification Devices Market Outlook, By Peripheral Artery Disease (2018-2027) ($MN)
Table 11 Global Plaque Modification Devices Market Outlook, By End User (2018-2027) ($MN)
Table 12 Global Plaque Modification Devices Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 13 Global Plaque Modification Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 14 Global Plaque Modification Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Table 15 North America Plaque Modification Devices Market Outlook, By Country (2018-2027) ($MN)
Table 16 North America Plaque Modification Devices Market Outlook, By Product (2018-2027) ($MN)
Table 17 North America Plaque Modification Devices Market Outlook, By Atherectomy Devices (2018-2027) ($MN)
Table 18 North America Plaque Modification Devices Market Outlook, By Chronic Total Occlusion (CTO) Devices (2018-2027) ($MN)
Table 19 North America Plaque Modification Devices Market Outlook, By Embolic Protection Devices (EPD) (2018-2027) ($MN)
Table 20 North America Plaque Modification Devices Market Outlook, By Thrombectomy Devices (2018-2027) ($MN)
Table 21 North America Plaque Modification Devices Market Outlook, By Application (2018-2027) ($MN)
Table 22 North America Plaque Modification Devices Market Outlook, By Coronary Artery Disease (2018-2027) ($MN)
Table 23 North America Plaque Modification Devices Market Outlook, By Neurovascular Disease (2018-2027) ($MN)
Table 24 North America Plaque Modification Devices Market Outlook, By Peripheral Artery Disease (2018-2027) ($MN)
Table 25 North America Plaque Modification Devices Market Outlook, By End User (2018-2027) ($MN)
Table 26 North America Plaque Modification Devices Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 27 North America Plaque Modification Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 28 North America Plaque Modification Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Table 29 Europe Plaque Modification Devices Market Outlook, By Country (2018-2027) ($MN)
Table 30 Europe Plaque Modification Devices Market Outlook, By Product (2018-2027) ($MN)
Table 31 Europe Plaque Modification Devices Market Outlook, By Atherectomy Devices (2018-2027) ($MN)
Table 32 Europe Plaque Modification Devices Market Outlook, By Chronic Total Occlusion (CTO) Devices (2018-2027) ($MN)
Table 33 Europe Plaque Modification Devices Market Outlook, By Embolic Protection Devices (EPD) (2018-2027) ($MN)
Table 34 Europe Plaque Modification Devices Market Outlook, By Thrombectomy Devices (2018-2027) ($MN)
Table 35 Europe Plaque Modification Devices Market Outlook, By Application (2018-2027) ($MN)
Table 36 Europe Plaque Modification Devices Market Outlook, By Coronary Artery Disease (2018-2027) ($MN)
Table 37 Europe Plaque Modification Devices Market Outlook, By Neurovascular Disease (2018-2027) ($MN)
Table 38 Europe Plaque Modification Devices Market Outlook, By Peripheral Artery Disease (2018-2027) ($MN)
Table 39 Europe Plaque Modification Devices Market Outlook, By End User (2018-2027) ($MN)
Table 40 Europe Plaque Modification Devices Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 41 Europe Plaque Modification Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 42 Europe Plaque Modification Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Table 43 Asia Pacific Plaque Modification Devices Market Outlook, By Country (2018-2027) ($MN)
Table 44 Asia Pacific Plaque Modification Devices Market Outlook, By Product (2018-2027) ($MN)
Table 45 Asia Pacific Plaque Modification Devices Market Outlook, By Atherectomy Devices (2018-2027) ($MN)
Table 46 Asia Pacific Plaque Modification Devices Market Outlook, By Chronic Total Occlusion (CTO) Devices (2018-2027) ($MN)
Table 47 Asia Pacific Plaque Modification Devices Market Outlook, By Embolic Protection Devices (EPD) (2018-2027) ($MN)
Table 48 Asia Pacific Plaque Modification Devices Market Outlook, By Thrombectomy Devices (2018-2027) ($MN)
Table 49 Asia Pacific Plaque Modification Devices Market Outlook, By Application (2018-2027) ($MN)
Table 50 Asia Pacific Plaque Modification Devices Market Outlook, By Coronary Artery Disease (2018-2027) ($MN)
Table 51 Asia Pacific Plaque Modification Devices Market Outlook, By Neurovascular Disease (2018-2027) ($MN)
Table 52 Asia Pacific Plaque Modification Devices Market Outlook, By Peripheral Artery Disease (2018-2027) ($MN)
Table 53 Asia Pacific Plaque Modification Devices Market Outlook, By End User (2018-2027) ($MN)
Table 54 Asia Pacific Plaque Modification Devices Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 55 Asia Pacific Plaque Modification Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 56 Asia Pacific Plaque Modification Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Table 57 South America Plaque Modification Devices Market Outlook, By Country (2018-2027) ($MN)
Table 58 South America Plaque Modification Devices Market Outlook, By Product (2018-2027) ($MN)
Table 59 South America Plaque Modification Devices Market Outlook, By Atherectomy Devices (2018-2027) ($MN)
Table 60 South America Plaque Modification Devices Market Outlook, By Chronic Total Occlusion (CTO) Devices (2018-2027) ($MN)
Table 61 South America Plaque Modification Devices Market Outlook, By Embolic Protection Devices (EPD) (2018-2027) ($MN)
Table 62 South America Plaque Modification Devices Market Outlook, By Thrombectomy Devices (2018-2027) ($MN)
Table 63 South America Plaque Modification Devices Market Outlook, By Application (2018-2027) ($MN)
Table 64 South America Plaque Modification Devices Market Outlook, By Coronary Artery Disease (2018-2027) ($MN)
Table 65 South America Plaque Modification Devices Market Outlook, By Neurovascular Disease (2018-2027) ($MN)
Table 66 South America Plaque Modification Devices Market Outlook, By Peripheral Artery Disease (2018-2027) ($MN)
Table 67 South America Plaque Modification Devices Market Outlook, By End User (2018-2027) ($MN)
Table 68 South America Plaque Modification Devices Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 69 South America Plaque Modification Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 70 South America Plaque Modification Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Table 71 Middle East & Africa Plaque Modification Devices Market Outlook, By Country (2018-2027) ($MN)
Table 72 Middle East & Africa Plaque Modification Devices Market Outlook, By Product (2018-2027) ($MN)
Table 73 Middle East & Africa Plaque Modification Devices Market Outlook, By Atherectomy Devices (2018-2027) ($MN)
Table 74 Middle East & Africa Plaque Modification Devices Market Outlook, By Chronic Total Occlusion (CTO) Devices (2018-2027) ($MN)
Table 75 Middle East & Africa Plaque Modification Devices Market Outlook, By Embolic Protection Devices (EPD) (2018-2027) ($MN)
Table 76 Middle East & Africa Plaque Modification Devices Market Outlook, By Thrombectomy Devices (2018-2027) ($MN)
Table 77 Middle East & Africa Plaque Modification Devices Market Outlook, By Application (2018-2027) ($MN)
Table 78 Middle East & Africa Plaque Modification Devices Market Outlook, By Coronary Artery Disease (2018-2027) ($MN)
Table 79 Middle East & Africa Plaque Modification Devices Market Outlook, By Neurovascular Disease (2018-2027) ($MN)
Table 80 Middle East & Africa Plaque Modification Devices Market Outlook, By Peripheral Artery Disease (2018-2027) ($MN)
Table 81 Middle East & Africa Plaque Modification Devices Market Outlook, By End User (2018-2027) ($MN)
Table 82 Middle East & Africa Plaque Modification Devices Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 83 Middle East & Africa Plaque Modification Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 84 Middle East & Africa Plaque Modification Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN) "

Plaque Modification Devices - Global Market Outlook (2019-2027)

.